Overview

HCC1


'HCC1' can also refer to...

HCC1

SPP1 polymorphisms associated with HBV clearance and HCC occurrence

P1–080DOES THE USE OF SORAFENIB FOR ADVANCED HCC FOLLOW APPROPRIATE SELECTION CRITERIA?

Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo

365OPhase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC)

Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion

MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1

Developmental Toxicity and Genotoxicity Studies of 1,1,1,3,3,3-Hexachloropropane (HCC-230fa) in Rats

Subchronic Inhalation Toxicity of the Chlorinated Propane 1,1,1,3,3,3-Hexachloropropane (HCC-230fa)

HCC1, the Arabidopsis homologue of the yeast mitochondrial copper chaperone SCO1, is essential for embryonic development

P1–082PATTERNS OF EFFICACY, TOXICITY AND TREATMENT DISCONTINUATION IN HCC PATIENTS RECEIVING CAPECITABINE MONOTHERAPY

214PHBx upregulated lncRNA facilitates HCC tumor growth via suppression of p27Kip1/CDK2

HCC-Associated Protein HCAP1, a Variant of GEMIN4, Interacts with Zinc-Finger Proteins

The TNF-α/ROS/HIF-1-induced Upregulation of FoxMI Expression Promotes HCC Proliferation and Resistance to Apoptosis

O2-14-1Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study

P-140Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

Transcriptional regulation of STAT3 by SPTBN1 and SMAD3 in HCC through cAMP-response element-binding proteins ATF3 and CREB2

Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study

1645PAnalysis of programmed death-ligand 1 (PD-L1) expression, transforming growth factor (TGF)-β gene expression signatures (GES) and tumor-infiltrating immune cells (IC) in hepatocellular carcinoma (HCC): Rationale for targeting PD-L1- and TGF-β

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

An RNA-binding protein (hepatocellular carcinoma protein 1, transcription coactivator CAPER, RNA binding motif protein 39, 530 aa) and possible splicing factor that colocalizes with core spliceosomal proteins. A mouse protein with high sequence similarity may act as a transcriptional coactivator for JUN/AP1 and oestrogen receptors. Multiple transcript variants have been found.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.